Skip to content

Organon OGN Work in process

Work in process at other companies

Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$35.1M+26.7%
Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Biogen logo
BiogenBIIB
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's work in process?
Organon (OGN) reported work in process of $800M in Q1 2026.
How has Organon's work in process changed year-over-year?
Organon's work in process increased by 16.3% year-over-year, from $688M to $800M.
What is the long-term trend for Organon's work in process?
Over 5 years (2020 to 2025), Organon's work in process has grown at a 5.9% compound annual growth rate (CAGR), from $595M to $791M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.